Filana Therapeutics Inc. research and ratings by Barron's. View FLNA revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.
As FiercePharma explains, the company is attempting to rebrand itself in the wake of a Justice Department investigation, a class-action lawsuit, and a failed attempt at treating Alzheimer’s. Plus: The ...
Filana Therapeutics, Inc. (formerly Cassava Sciences, Inc.) (NASDAQ: FLNA, “Filana Therapeutics”, the “Company”), a biotechnology company focused on developing novel medicines to modulate the filamin ...
New corporate identity reflects the Company’s mission to develop novel medicines to modulate filamin A and address unmet needs in treating ...
Two Manchester researchers, Professor Bruce Grieve and Professor Hujun Yin, were recognised with the Pioneering UK-US Breakthroughs (PUB) award, by the UK Research and Innovation in the British ...
Cassava Sciences rebrands to Filana Therapeutics (FLNA) on March 11, 2026, focusing on filamin A CNS therapies for TSC epilepsy—get the latest update.
WASHINGTON — Neil H. Shubin, Robert R. Bensley Distinguished Service Professor of Organismal Biology and Anatomy and vice dean for academic advancement at the University of Chicago, has been elected ...
Live webcast of event on February 27 at 8:00 a.m. ET will include participation of globally renowned gynecological oncology KOLs from the US and EU KOL panel to discuss maturing data from the ACR-368 ...
Gilead Sciences is buying CAR-T therapy partner Arcellx for $7.8 billion. Novo Nordisk struck a licensing deal with Boston-based Vivtex Corp. for oral peptide and protein drugs to treat obesity, ...
SINGAPORE (AP) — SINGAPORE (AP) — Wave Life Sciences Pte. Ltd. (WVE) on Thursday reported a loss of $53.2 million in its fourth quarter. On a per-share basis, the Singapore-based company said it had a ...
Abbott Laboratories sold $20 billion of bonds to help fund its acquisition of cancer-screening company Exact Sciences Corp. on Monday, one of the US high-grade market’s biggest offerings this year.